Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sexual dysfunction is a common side effect of most antidepressants. Lower rates are reported with some newer agents such as reboxetine and bupropion. The evidence base for its management is limited but growing, with most approaches only tested in a small number of trials. Available strategies include watchful waiting, the use of short drug holidays, and a change of antidepressant. Many specific antidotes have been trialed but with lack of convincing benefit in most cases. However, where antidepressants cause erectile dysfunction, the use of sildenafil has the largest and most consistent evidence base.

Original publication

DOI

10.1007/s11920-006-0047-6

Type

Journal article

Journal

Curr Psychiatry Rep

Publication Date

12/2006

Volume

8

Pages

431 - 436

Keywords

Antidepressive Agents, Bupropion, Buspirone, Depressive Disorder, Erectile Dysfunction, Female, Ginkgo biloba, Granisetron, Humans, Male, Randomized Controlled Trials as Topic, Sexual Dysfunction, Physiological